4//SEC Filing
TETRAULT LYNN A. 4
Accession 0001077183-25-000100
CIK 0001077183other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:26 PM ET
Size
15.1 KB
Accession
0001077183-25-000100
Insider Transaction Report
Form 4
TETRAULT LYNN A.
Director
Transactions
- Purchase
Common Stock
2025-05-09$8.14/sh+7,000$56,974→ 7,000 total(indirect: By IRA)
Holdings
- 3,448
Stock Option (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - 972
Stock Option (Right to Buy)
Exercise: $41.76From: 2022-10-11Exp: 2028-10-11→ Common Stock (972 underlying) - 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 61,398
Common Stock
- 2,136
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (2,136 underlying) - 13,882
Stock Option (Right to Buy)
Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying) - 3,714
Stock Option (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 12,254
Restricted Stock Unit
Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying)
Footnotes (1)
- [F1]Once vested, the shares of common stock are not subject to expiration.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001645512
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 5:26 PM ET
- Size
- 15.1 KB